Exchange: NASDAQ·Updated 07:30 PM EST
DARE logo

DARE Dare Bioscience Inc

$0.417
$0.0446
(9.87%)
Today
Closed $0.4074
$0.0096
(2.36%)
After Hours
Reported EarningsNov 16
Mkt Cap$8.01M
Vol173,238.00

About DARE

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley on November 28, 2005 and is headquartered in San Diego, CA.
23

Extremely Bearish Sentiment

How do you feel about DARE?

DM3D
$DARE "...CEO, discusses numerous potential value drivers expected to power the Company’s next phase of growth and commercial success." So I read that to say we need a new crop of suckers to keep paying our salaries. They've already bleed the current crop dry with RS and dilution. There is nothing left of my "investment" here so no ROI for me. They are very good at enticement!
4
Delthefunkeehomosapian
$DARE They just do not care at all about shareholder value. They have limited avenues to gain compliance in my opinion.
2
AlertsAndNews
$DARE DARE Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum
2
Green_Party
$DARE This is obviously terrible. Best case scenario is that this is the dilution they need to fund the company for the next few quarters and we can see what happens with Ovaprene/Dare to Play etc. Worst case scenario is that the next round of dilution hasn't even started yet.
1
TravisA9
$DARE Officially closed my short this morning. Thanks to whoever ended their misery, I appreciate the liquidity. $6.60 down to $0.45, 80% profit (post borrow fees) will do just fine. Good luck Sabrina!
1
StocktwitsEarnings
$DARE Q3 '26 Earnings Results & Recap Dar Bioscience reported Q3 2026 revenue of $47,628, operating expenses of $2,959,294, net loss of $3,157,936, and basic and diluted loss per share of $0.18.
Green_Party
$DARE I'll believe it when I see it, but they said Dare to Play should start dispensing this month. Also some talk about selling some products on amazon, which could be something. I guess we'll see. Hopefully we get a better timeline about Ovaprene study completion and ideas about what they'll do after in early 2027.
Stock_Catcher
$DARE Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum

Advertisement|Remove ads.